D. E. Shaw & Co., Inc. Horizon Therapeutics Public LTD CO Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $103 Million - $120 Million	1,035,866 Added 28.13%	4,718,246 $546 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $140 Million - $164 Million	1,457,042 Added 65.48%	3,682,380 $379 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $230 Million - $243 Million	2,145,248 Added 2678.55%	2,225,338 $243 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $20.8 Million - $38 Million	-334,088 Reduced 80.66%	80,090 $9.11 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $23 Million - $33.1 Million	390,368 Added 1639.51%	414,178 $25.6 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $19.6 Million - $28.7 Million	-246,964 Reduced 91.21%	23,810 $1.9 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $10.8 Million - $13.7 Million	124,881 Added 85.6%	270,774 $28.5 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $10.8 Million - $13.1 Million	-109,344 Reduced 42.84%	145,893 $15.7 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $15.6 Million - $18.7 Million	-169,464 Reduced 39.9%	255,237 $28 Million
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $103 Million - $114 Million	-1,192,747 Reduced 73.74%	424,701 $39.8 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $49.3 Million - $65.5 Million	-686,298 Reduced 29.79%	1,617,448 $149 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $49.3 Million - $62.1 Million	-735,867 Reduced 24.21%	2,303,746 $169 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $3.71 Million - $5.37 Million	67,181 Added 2.26%	3,039,613 $236 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $40.6 Million - $76.7 Million	-1,345,321 Reduced 31.16%	2,972,432 $165 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $20.3 Million - $31.5 Million	-816,404 Reduced 15.9%	4,317,753 $128 Million
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $618,737 - $892,217	24,331 Added 0.48%	5,134,157 $186 Million
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $273,631 - $332,759	11,897 Added 0.23%	5,109,826 $139 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $116 Million - $145 Million	5,097,929 New	5,097,929 $123 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account